Banzel® (rufinamide) tablets
Approval Date: Aug 2022
Note: First-Time Generic
Indicated for the adjunctive treatment of seizures associated with Lennox-Gastaut Syndrome
Briviact (brivaracetam) tablets
Approval Date: Jun 2022
Note: First-Time Generic
Indicated for the treatment of partial-onset seizures.
Zonisade (zonisamide) oral suspension
Approval Date: Jul 2022
Note: New Dosage or Formulation
Indicated as an adjunctive therapy for the treatment of partial-onset seizures, this approval is for the first liquid formulation of zonisamide.
Vimpat (lacosamide) tablets
Approval Date: Mar 2022
Note: First-Time Generic
A first-time generic for Vimpat, this drug treats partial onset seizures
Aptiom® (eslicarbazepine acetate) tablets
Approval Date: Jun 2021
Note: First-Time Generic
This is the first time a generic has been approved for Aptiom. For the adjunctive treatment of partial-onset seizures
